vs

Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and OPEN TEXT CORP (OTEX). Click either name above to swap in a different company.

OPEN TEXT CORP is the larger business by last-quarter revenue ($1.3B vs $1.0B, roughly 1.3× Everus Construction Group, Inc.). OPEN TEXT CORP runs the higher net margin — 12.7% vs 5.5%, a 7.2% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs -0.6%). OPEN TEXT CORP produced more free cash flow last quarter ($279.4M vs $23.5M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs -4.3%).

ECG vs OTEX — Head-to-Head

Bigger by revenue
OTEX
OTEX
1.3× larger
OTEX
$1.3B
$1.0B
ECG
Growing faster (revenue YoY)
ECG
ECG
+33.7% gap
ECG
33.2%
-0.6%
OTEX
Higher net margin
OTEX
OTEX
7.2% more per $
OTEX
12.7%
5.5%
ECG
More free cash flow
OTEX
OTEX
$256.0M more FCF
OTEX
$279.4M
$23.5M
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
-4.3%
OTEX

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ECG
ECG
OTEX
OTEX
Revenue
$1.0B
$1.3B
Net Profit
$55.3M
$168.1M
Gross Margin
11.6%
74.0%
Operating Margin
6.8%
22.0%
Net Margin
5.5%
12.7%
Revenue YoY
33.2%
-0.6%
Net Profit YoY
60.4%
-26.9%
EPS (diluted)
$1.09
$0.66

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECG
ECG
OTEX
OTEX
Q4 25
$1.0B
$1.3B
Q3 25
$986.8M
$1.3B
Q2 25
$921.5M
$1.3B
Q1 25
$826.6M
$1.3B
Q4 24
$759.6M
$1.3B
Q3 24
$761.0M
$1.3B
Q2 24
$703.4M
$1.4B
Q1 24
$625.7M
$1.4B
Net Profit
ECG
ECG
OTEX
OTEX
Q4 25
$55.3M
$168.1M
Q3 25
$57.0M
$146.6M
Q2 25
$52.8M
$28.8M
Q1 25
$36.7M
$92.8M
Q4 24
$34.5M
$229.9M
Q3 24
$41.8M
$84.4M
Q2 24
$39.0M
$248.2M
Q1 24
$28.2M
$98.3M
Gross Margin
ECG
ECG
OTEX
OTEX
Q4 25
11.6%
74.0%
Q3 25
12.6%
72.8%
Q2 25
13.0%
72.3%
Q1 25
11.2%
71.6%
Q4 24
11.4%
73.3%
Q3 24
11.8%
71.7%
Q2 24
12.6%
72.5%
Q1 24
11.9%
73.0%
Operating Margin
ECG
ECG
OTEX
OTEX
Q4 25
6.8%
22.0%
Q3 25
7.3%
21.0%
Q2 25
7.9%
13.9%
Q1 25
6.2%
16.7%
Q4 24
6.1%
22.2%
Q3 24
7.1%
16.3%
Q2 24
7.3%
14.2%
Q1 24
6.2%
15.7%
Net Margin
ECG
ECG
OTEX
OTEX
Q4 25
5.5%
12.7%
Q3 25
5.8%
11.4%
Q2 25
5.7%
2.2%
Q1 25
4.4%
7.4%
Q4 24
4.5%
17.2%
Q3 24
5.5%
6.6%
Q2 24
5.5%
18.2%
Q1 24
4.5%
6.8%
EPS (diluted)
ECG
ECG
OTEX
OTEX
Q4 25
$1.09
$0.66
Q3 25
$1.11
$0.58
Q2 25
$1.03
$0.11
Q1 25
$0.72
$0.35
Q4 24
$0.68
$0.87
Q3 24
$0.82
$0.32
Q2 24
$0.76
$0.91
Q1 24
$0.55
$0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECG
ECG
OTEX
OTEX
Cash + ST InvestmentsLiquidity on hand
$1.3B
Total DebtLower is stronger
$281.5M
$6.4B
Stockholders' EquityBook value
$629.8M
$4.0B
Total Assets
$1.7B
$13.6B
Debt / EquityLower = less leverage
0.45×
1.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECG
ECG
OTEX
OTEX
Q4 25
$1.3B
Q3 25
$1.1B
Q2 25
$1.2B
Q1 25
$1.3B
Q4 24
$1.1B
Q3 24
$553.0K
$1.0B
Q2 24
$1.3B
Q1 24
$1.1B
Total Debt
ECG
ECG
OTEX
OTEX
Q4 25
$281.5M
$6.4B
Q3 25
$285.1M
$6.4B
Q2 25
$288.6M
$6.4B
Q1 25
$292.1M
$6.4B
Q4 24
$295.6M
$6.4B
Q3 24
$6.4B
Q2 24
$6.4B
Q1 24
$8.4B
Stockholders' Equity
ECG
ECG
OTEX
OTEX
Q4 25
$629.8M
$4.0B
Q3 25
$573.0M
$4.0B
Q2 25
$514.4M
$3.9B
Q1 25
$460.2M
$4.1B
Q4 24
$422.6M
$4.2B
Q3 24
$453.3M
$4.1B
Q2 24
$490.0M
$4.2B
Q1 24
$464.3M
$4.1B
Total Assets
ECG
ECG
OTEX
OTEX
Q4 25
$1.7B
$13.6B
Q3 25
$1.6B
$13.5B
Q2 25
$1.5B
$13.8B
Q1 25
$1.4B
$13.8B
Q4 24
$1.3B
$13.7B
Q3 24
$1.3B
$13.8B
Q2 24
$14.2B
Q1 24
$16.4B
Debt / Equity
ECG
ECG
OTEX
OTEX
Q4 25
0.45×
1.58×
Q3 25
0.50×
1.61×
Q2 25
0.56×
1.62×
Q1 25
0.63×
1.55×
Q4 24
0.70×
1.51×
Q3 24
1.55×
Q2 24
1.52×
Q1 24
2.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECG
ECG
OTEX
OTEX
Operating Cash FlowLast quarter
$48.2M
$318.7M
Free Cash FlowOCF − Capex
$23.5M
$279.4M
FCF MarginFCF / Revenue
2.3%
21.1%
Capex IntensityCapex / Revenue
2.4%
3.0%
Cash ConversionOCF / Net Profit
0.87×
1.90×
TTM Free Cash FlowTrailing 4 quarters
$90.0M
$878.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECG
ECG
OTEX
OTEX
Q4 25
$48.2M
$318.7M
Q3 25
$76.2M
$147.8M
Q2 25
$25.3M
$158.2M
Q1 25
$7.1M
$402.2M
Q4 24
$348.0M
Q3 24
$78.9M
$-77.8M
Q2 24
$185.2M
Q1 24
$21.9M
$384.7M
Free Cash Flow
ECG
ECG
OTEX
OTEX
Q4 25
$23.5M
$279.4M
Q3 25
$65.7M
$101.2M
Q2 25
$12.3M
$124.0M
Q1 25
$-11.4M
$373.8M
Q4 24
$306.7M
Q3 24
$60.9M
$-117.1M
Q2 24
$145.2M
Q1 24
$12.6M
$348.2M
FCF Margin
ECG
ECG
OTEX
OTEX
Q4 25
2.3%
21.1%
Q3 25
6.7%
7.9%
Q2 25
1.3%
9.5%
Q1 25
-1.4%
29.8%
Q4 24
23.0%
Q3 24
8.0%
-9.2%
Q2 24
10.7%
Q1 24
2.0%
24.1%
Capex Intensity
ECG
ECG
OTEX
OTEX
Q4 25
2.4%
3.0%
Q3 25
1.1%
3.6%
Q2 25
1.4%
2.6%
Q1 25
2.2%
2.3%
Q4 24
3.1%
Q3 24
2.4%
3.1%
Q2 24
2.9%
Q1 24
1.5%
2.5%
Cash Conversion
ECG
ECG
OTEX
OTEX
Q4 25
0.87×
1.90×
Q3 25
1.34×
1.01×
Q2 25
0.48×
5.49×
Q1 25
0.19×
4.33×
Q4 24
1.51×
Q3 24
1.89×
-0.92×
Q2 24
0.75×
Q1 24
0.77×
3.91×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

OTEX
OTEX

Transferred At Point In Time$184.2M14%
Cybersecurity Enterprise Product$174.5M13%
Business Network Product$159.8M12%
Business Network Cloud Services And Subscriptions$151.4M11%
Content Cloud Services And Subscriptions$137.9M10%
Cybersecurity SMB Consumer Product$127.6M10%
Application Delivery Management Product$120.1M9%
IT Operations Management Product$113.3M9%
Professional Service And Other$82.5M6%
Analytics Product$58.1M4%
IT Operations Management Cloud Services And Subscriptions$7.8M1%

Related Comparisons